Industry: Chemical & Material
Published Date: 2026-06-05
Pages: 135 Pages
Report ld: 6011500
Request Sample
Customized Report
Glucose Dehydrogenase Market Size(US$)

CAGR 2026-2032
6.8%
Market Size,2032
USD 562
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Glucose Dehydrogenase was estimated to be worth US$ 358 million in 2025 and is projected to reach US$ 562 million, growing at a CAGR of 6.8% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Glucose Dehydrogenase cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Glucose dehydrogenase (GDH) is an oxidoreductase that catalyzes the oxidation of glucose to gluconolactone while reducing cofactors such as NAD⁺, PQQ, or FAD. It is widely used in blood glucose monitoring, biosensors, in vitro diagnostics (IVD), and biocatalysis. Depending on cofactors, GDH is classified into NAD-dependent, FAD-dependent, and PQQ-dependent types, with PQQ-GDH being widely used in continuous glucose monitoring (CGM) systems. In 2025, global sales volume of glucose dehydrogenase amounted to 341 tons, with an average selling price of $1,050 per Kg and an industry gross margin of 50%–75%. The glucose dehydrogenase industry chain consists of upstream raw materials and strain engineering, midstream enzyme manufacturing, and downstream applications. The upstream segment includes genetically engineered strains (e.g., E. coli, Bacillus subtilis), expression vectors, and fermentation media, with high technical barriers, especially for PQQ-GDH systems. The midstream involves enzyme production through fermentation, purification, lyophilization, and stabilization, representing the core value-added stage. Downstream applications include IVD (glucose test strips, CGM sensors), biosensors, food testing, and biocatalysis. With rising diabetes prevalence and CGM adoption, medical demand is rapidly increasing. The industry is also shifting toward higher stability, longer enzyme lifespan, and reduced interference, driving recombinant enzyme engineering as a key R&D direction.
Key market drivers for glucose dehydrogenase (GDH) include the growing global diabetic population, which continues to increase demand for glucose monitoring; rapid adoption of continuous glucose monitoring (CGM) systems, where GDH serves as a core biorecognition enzyme; rising penetration of point-of-care testing (POCT) devices in primary healthcare and homecare settings; advances in biotechnology that improve recombinant GDH production efficiency and reduce manufacturing costs; and expanding applications in food safety testing and industrial biocatalysis. In addition, high-stability technologies such as FAD-GDH are gradually replacing conventional glucose oxidase (GOx) systems in high-end diagnostics. Global aging trends and increasing chronic disease management demand are also strengthening the importance of GDH in healthcare diagnostics. On the risk side, GDH still faces competition from alternative enzyme technologies such as GOx, which retains cost advantages in some low-end applications. Technical barriers related to engineered strains, expression systems, and fermentation processes remain high, making market entry difficult for new players. Strict IVD and medical device regulations, especially in the US and European markets, may slow product approvals and commercialization. Fluctuations in fermentation media, purification materials, and bioprocessing costs can also affect profitability. In addition, the CGM market is highly concentrated, giving major downstream players strong bargaining power over upstream GDH suppliers. Diagnostic-grade GDH products also require extremely high stability, anti-interference capability, and batch consistency, increasing ongoing R&D and quality-control investment requirements.
This report provides a comprehensive view of the global market for Glucose Dehydrogenase, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Glucose Dehydrogenase market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Glucose Dehydrogenase.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Glucose Dehydrogenase manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Glucose Dehydrogenase sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Glucose Dehydrogenase sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Glucose Dehydrogenase Product Introduction
1.2 Global Glucose Dehydrogenase Market Size Forecast
1.2.1 Global Glucose Dehydrogenase Sales Value (2021–2032)
1.2.2 Global Glucose Dehydrogenase Sales Volume (2021–2032)
1.2.3 Global Glucose Dehydrogenase Sales Price (2021–2032)
1.3 Glucose Dehydrogenase Market Trends & Drivers
1.3.1 Glucose Dehydrogenase Industry Trends
1.3.2 Glucose Dehydrogenase Market Drivers & Opportunities
1.3.3 Glucose Dehydrogenase Market Challenges
1.3.4 Glucose Dehydrogenase Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Glucose Dehydrogenase Players Revenue Ranking (2025)
2.2 Global Glucose Dehydrogenase Revenue by Company (2021–2026)
2.3 Global Glucose Dehydrogenase Sales Volume Ranking of Players (2025)
2.4 Global Glucose Dehydrogenase Sales Volume by Company (2021–2026)
2.5 Global Glucose Dehydrogenase Average Price by Company (2021–2026)
2.6 Key Manufacturers Glucose Dehydrogenase Manufacturing Base and Headquarters
2.7 Key Manufacturers Glucose Dehydrogenase Product Offerings
2.8 Key Manufacturers Start of Mass Production of Glucose Dehydrogenase
2.9 Glucose Dehydrogenase Market Competitive Analysis
2.9.1 Glucose Dehydrogenase Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Glucose Dehydrogenase Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Glucose Dehydrogenase revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Glucose Dehydrogenase Market Classification
3.1 Introduction by Type
3.1.1 NAD-dependent GDH
3.1.2 FAD-dependent GDH
3.1.3 PQQ-dependent GDH
3.1.4 Global Glucose Dehydrogenase Sales Value by Type
3.1.4.1 Global Glucose Dehydrogenase Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Glucose Dehydrogenase Sales Value, by Type (2021–2032)
3.1.4.3 Global Glucose Dehydrogenase Sales Value, by Type (%), 2021–2032
3.1.5 Global Glucose Dehydrogenase Sales Volume by Type
3.1.5.1 Global Glucose Dehydrogenase Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Glucose Dehydrogenase Sales Volume, by Type (2021–2032)
3.1.5.3 Global Glucose Dehydrogenase Sales Volume, by Type (%), 2021–2032
3.1.6 Global Glucose Dehydrogenase Average Price by Type (2021–2032)
3.2 Introduction by Source
3.2.1 Microbial-derived
3.2.2 Recombinant Enzyme
3.2.3 Native Extraction
3.2.4 Global Glucose Dehydrogenase Sales Value by Source
3.2.4.1 Global Glucose Dehydrogenase Sales Value by Source (2021 vs 2025 vs 2032)
3.2.4.2 Global Glucose Dehydrogenase Sales Value, by Source (2021–2032)
3.2.4.3 Global Glucose Dehydrogenase Sales Value, by Source (%), 2021–2032
3.2.5 Global Glucose Dehydrogenase Sales Volume by Source
3.2.5.1 Global Glucose Dehydrogenase Sales Volume by Source (2021 vs 2025 vs 2032)
3.2.5.2 Global Glucose Dehydrogenase Sales Volume, by Source (2021–2032)
3.2.5.3 Global Glucose Dehydrogenase Sales Volume, by Source (%), 2021–2032
3.2.6 Global Glucose Dehydrogenase Average Price by Source (2021–2032)
3.3 Introduction by Form
3.3.1 Lyophilized Powder
3.3.2 Liquid Enzyme
3.3.3 Immobilized Enzyme
3.3.4 Global Glucose Dehydrogenase Sales Value by Form
3.3.4.1 Global Glucose Dehydrogenase Sales Value by Form (2021 vs 2025 vs 2032)
3.3.4.2 Global Glucose Dehydrogenase Sales Value, by Form (2021–2032)
3.3.4.3 Global Glucose Dehydrogenase Sales Value, by Form (%), 2021–2032
3.3.5 Global Glucose Dehydrogenase Sales Volume by Form
3.3.5.1 Global Glucose Dehydrogenase Sales Volume by Form (2021 vs 2025 vs 2032)
3.3.5.2 Global Glucose Dehydrogenase Sales Volume, by Form (2021–2032)
3.3.5.3 Global Glucose Dehydrogenase Sales Volume, by Form (%), 2021–2032
3.3.6 Global Glucose Dehydrogenase Average Price by Form (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Glucose Test Strips
4.1.2 Continuous Glucose Monitoring
4.1.3 IVD / POCT Testing
4.1.4 Others
4.2 Global Glucose Dehydrogenase Sales Value by Application
4.2.1 Global Glucose Dehydrogenase Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Glucose Dehydrogenase Sales Value, by Application (2021–2032)
4.2.3 Global Glucose Dehydrogenase Sales Value, by Application (%), 2021–2032
4.3 Global Glucose Dehydrogenase Sales Volume by Application
4.3.1 Global Glucose Dehydrogenase Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Glucose Dehydrogenase Sales Volume, by Application (2021–2032)
4.3.3 Global Glucose Dehydrogenase Sales Volume, by Application (%), 2021–2032
4.4 Global Glucose Dehydrogenase Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Glucose Dehydrogenase Sales Value by Region
5.1.1 Global Glucose Dehydrogenase Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Glucose Dehydrogenase Sales Value by Region (2021–2026)
5.1.3 Global Glucose Dehydrogenase Sales Value by Region (2027–2032)
5.1.4 Global Glucose Dehydrogenase Sales Value by Region (%), 2021–2032
5.2 Global Glucose Dehydrogenase Sales Volume by Region
5.2.1 Global Glucose Dehydrogenase Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Glucose Dehydrogenase Sales Volume by Region (2021–2026)
5.2.3 Global Glucose Dehydrogenase Sales Volume by Region (2027–2032)
5.2.4 Global Glucose Dehydrogenase Sales Volume by Region (%), 2021–2032
5.3 Global Glucose Dehydrogenase Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Glucose Dehydrogenase Sales Value, 2021–2032
5.4.2 North America Glucose Dehydrogenase Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Glucose Dehydrogenase Sales Value, 2021–2032
5.5.2 Europe Glucose Dehydrogenase Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Glucose Dehydrogenase Sales Value, 2021–2032
5.6.2 Asia Pacific Glucose Dehydrogenase Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Glucose Dehydrogenase Sales Value, 2021–2032
5.7.2 South America Glucose Dehydrogenase Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Glucose Dehydrogenase Sales Value, 2021–2032
5.8.2 Middle East & Africa Glucose Dehydrogenase Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Glucose Dehydrogenase Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Glucose Dehydrogenase Sales Value and Sales Volume
6.2.1 Key Countries/Regions Glucose Dehydrogenase Sales Value, 2021–2032
6.2.2 Key Countries/Regions Glucose Dehydrogenase Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Glucose Dehydrogenase Sales Value, 2021–2032
6.3.2 United States Glucose Dehydrogenase Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Glucose Dehydrogenase Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Glucose Dehydrogenase Sales Value, 2021–2032
6.4.2 Europe Glucose Dehydrogenase Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Glucose Dehydrogenase Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Glucose Dehydrogenase Sales Value, 2021–2032
6.5.2 China Glucose Dehydrogenase Sales Value by Type (%), 2025 vs 2032
6.5.3 China Glucose Dehydrogenase Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Glucose Dehydrogenase Sales Value, 2021–2032
6.6.2 Japan Glucose Dehydrogenase Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Glucose Dehydrogenase Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Glucose Dehydrogenase Sales Value, 2021–2032
6.7.2 South Korea Glucose Dehydrogenase Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Glucose Dehydrogenase Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Glucose Dehydrogenase Sales Value, 2021–2032
6.8.2 Southeast Asia Glucose Dehydrogenase Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Glucose Dehydrogenase Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Glucose Dehydrogenase Sales Value, 2021–2032
6.9.2 India Glucose Dehydrogenase Sales Value by Type (%), 2025 vs 2032
6.9.3 India Glucose Dehydrogenase Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Sekisui Diagnostics
7.1.1 Sekisui Diagnostics Company Information
7.1.2 Sekisui Diagnostics Introduction and Business Overview
7.1.3 Sekisui Diagnostics Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Sekisui Diagnostics Glucose Dehydrogenase Product Offerings
7.1.5 Sekisui Diagnostics Recent Developments
7.2 Oriental Yeast
7.2.1 Oriental Yeast Company Information
7.2.2 Oriental Yeast Introduction and Business Overview
7.2.3 Oriental Yeast Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Oriental Yeast Glucose Dehydrogenase Product Offerings
7.2.5 Oriental Yeast Recent Developments
7.3 Codexis
7.3.1 Codexis Company Information
7.3.2 Codexis Introduction and Business Overview
7.3.3 Codexis Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Codexis Glucose Dehydrogenase Product Offerings
7.3.5 Codexis Recent Developments
7.4 BBI Solutions
7.4.1 BBI Solutions Company Information
7.4.2 BBI Solutions Introduction and Business Overview
7.4.3 BBI Solutions Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 BBI Solutions Glucose Dehydrogenase Product Offerings
7.4.5 BBI Solutions Recent Developments
7.5 SyncoZymes
7.5.1 SyncoZymes Company Information
7.5.2 SyncoZymes Introduction and Business Overview
7.5.3 SyncoZymes Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 SyncoZymes Glucose Dehydrogenase Product Offerings
7.5.5 SyncoZymes Recent Developments
7.6 Novozymes
7.6.1 Novozymes Company Information
7.6.2 Novozymes Introduction and Business Overview
7.6.3 Novozymes Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Novozymes Glucose Dehydrogenase Product Offerings
7.6.5 Novozymes Recent Developments
7.7 Johnson Matthey
7.7.1 Johnson Matthey Company Information
7.7.2 Johnson Matthey Introduction and Business Overview
7.7.3 Johnson Matthey Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Johnson Matthey Glucose Dehydrogenase Product Offerings
7.7.5 Johnson Matthey Recent Developments
7.8 Hzymes
7.8.1 Hzymes Company Information
7.8.2 Hzymes Introduction and Business Overview
7.8.3 Hzymes Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Hzymes Glucose Dehydrogenase Product Offerings
7.8.5 Hzymes Recent Developments
7.9 Gproan Biotech
7.9.1 Gproan Biotech Company Information
7.9.2 Gproan Biotech Introduction and Business Overview
7.9.3 Gproan Biotech Glucose Dehydrogenase Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Gproan Biotech Glucose Dehydrogenase Product Offerings
7.9.5 Gproan Biotech Recent Developments
8 Industry Chain Analysis
8.1 Glucose Dehydrogenase Industrial Chain
8.2 Glucose Dehydrogenase Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Glucose Dehydrogenase Sales Model
8.5.2 Sales Channels
8.5.3 Glucose Dehydrogenase Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Glucose Dehydrogenase market size was US$ 358 million in 2025 and is forecast to reach a readjusted size of US$ 562 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published Date: 2026-06-05
Pages: 129
USD 4250.00
(Single User License)
The global Glucose Dehydrogenase market is projected to grow from US$ 358 million in 2025 to US$ 562 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-06-05
Pages: 144
USD 4900.00
(Single User License)
The global Glucose Dehydrogenase market was valued at US$ 358 million in 2025 and is anticipated to reach US$ 562 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-06-05
Pages: 133
USD 2900.00
(Single User License)
The global Glucose Dehydrogenase market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 175
USD 4900.00
(Single User License)
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-16
Pages: 134
USD 3950.00
(Single User License)
The global Glucose Dehydrogenase market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2025-06-16
Pages: 174
USD 4900.00
(Single User License)
The global Glucose Dehydrogenase market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-16
Pages: 108
USD 4250.00
(Single User License)
The global market for Glucose Dehydrogenase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-06-16
Pages: 114
USD 2900.00
(Single User License)
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 93
USD 3950.00
(Single User License)
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 101
USD 3950.00
(Single User License)
The global Glucose Dehydrogenase market size was US$ 358 million in 2025 and is forecast to reach a readjusted size of US$ 562 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-06-05
Pages: 129
The global Glucose Dehydrogenase market is projected to grow from US$ 358 million in 2025 to US$ 562 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-06-05
Pages: 144
The global Glucose Dehydrogenase market was valued at US$ 358 million in 2025 and is anticipated to reach US$ 562 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-06-05
Pages: 133
The global Glucose Dehydrogenase market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 175
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-16
Pages: 134
The global Glucose Dehydrogenase market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2025-06-16
Pages: 174
The global Glucose Dehydrogenase market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-16
Pages: 108
The global market for Glucose Dehydrogenase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-06-16
Pages: 114
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 93
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 101
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now